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Title: Structure and function of the human respiratory syncytial virus M2-1 protein 
 




Human respiratory syncytial virus (HRSV) is a non-segmented negative stranded RNA 
virus and is recognized as the most important viral agent of lower respiratory tract 
infection worldwide, responsible for up to 199,000 deaths each year. The only FDA-
approved regime to prevent HRSV-mediated disease is pre-exposure administration of 
a humanized HRSV-specific monoclonal antibody, which although being effective, is 
not in widespread usage due to its cost. No HRSV vaccine exists and so there remains 
a strong need for alternative and complementary anti-HRSV therapies. The HRSV M2-
1 protein is a transcription factor and represents an attractive target for the development 
of antiviral compounds, based on its essential role in the viral replication cycle. To this 
end, a detailed analysis of M2-1 structure and  functions will aid in identifying rational 
targets for structure-based antiviral drug design that can be developed in future 
translational research. Here we present an overview of the current understanding of the 
structure and function of HRSV M2-1, drawing on additional information derived from 
its structural homologues from other related viruses. 
 
1.1. Introduction 
 RNA viruses can be divided into positive and negative sense groups based on 
the ability of their RNA genomes to act as messenger RNA (mRNA) for the production 
of proteins. In positive sense RNA viruses, the genome can be translated directly, while 
in negative sense RNA viruses, the input genome must undergo a copying event to 
produce coding sense mRNAs. The negative-sense RNA viruses (NSV) can be further 
divided into segmented (SNSV) and non-segmented negative strand viruses (NSNSV), 
depending on whether the genome is a single chain of ribonucleotides, or whether it is 
segmented into two or more separate RNA molecules. The group of NSNSVs 
encompasses pathogens of humans, animals and plants, and notable examples include 
rabies virus, Nipah virus, Ebola virus (EBOV) and human respiratory syncytial virus 
(HRSV), many of which are without effective preventative or therapeutic options to 
prevent disease (Palse et al. 1996; Tao and Ye 2010). 
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 HRSV is the leading cause of lower respiratory tract illness in infants, elderly 
and immunocompromised individuals, causing bronchiolitis and pneumonia. Early and 
recurrent infections have been linked to the development of asthma in later life, which 
has a significant economic burden (Bohmwald et al. 2016).  It has been estimated that 
all infants across the globe are infected with HRSV at least once during their first 2 
years of life. Mild infections have a recovery time of 1-2 weeks, however HRSV 
infection can be serious and often fatal, and estimates for the number of fatalities per 
year are put between 50,000 - 199,000 (Scheltema et al. 2017; Shi et al, 2017). 
Presently, no vaccine exists for HRSV and the only options to reduce HRSV-mediated 
disease is preventative administration of a humanized mouse monoclonal antibody 
directed to a neutralizing epitope on the fusion protein (F) preventing host cell entry. 
This molecule is known as Palivizumab (or Synagis), and is effective, providing short-
term protection to infants at high risk (Brady, 2015), although the cost of this treatment 
is a current barrier to its widespread usage (Hu and Robinson, 2010). Post exposure 
treatment for HRSV is limited to the FDA-approved administration of nebulized 
ribavirin (a guanine nucleotide analogue). However, this drug exhibits significant 
toxicity and its effectiveness has been questioned (Marcelin et al., 2014). Thus, there is 
an urgent need to develop new antivirals against HRSV.  
 This chapter describes the structure and function of the HRSV M2-1 protein, 
which is an essential transcription factor required for the synthesis of HRSV mRNAs. 
Determination of the high-resolution structure of M2-1, in combination with defining 
the structural basis of its function, could aid in the design of new antiviral compounds 
through structure-based drug design. 
 
1.2. The Virion 
 HRSV is classified in the Pneumoviridae family of the order Mononegavirales. 
HRSV virions are pleiomorphic, with a cell derived lipid membrane surrounding an 
internal ribonucleocapsid (RNP) complex comprising the HRSV RNA genome in 
association with multiple viral proteins. The genome is approximately 15,200 nt in 
length and includes 10 genes coding for 11 proteins (Figure 1.1). Of these 11 proteins, 
3 are associated with the RNP; the nucleoprotein (N), the RNA-dependent RNA 
polymerase (L), and the phoshoprotein (P). Three HRSV proteins are associated with 
the viral envelope, namely the fusion protein (F), the so-called attachment glycoprotein 
(G) and the small hydrophobic protein (SH) (Table 1). The matrix protein (M), is 
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situated below the viral envelope, and plays a pivotal role in virion assembly. NS1 and 
NS2 proteins are non-structural, being absent from the virion, and they play critical 
roles in overcoming the innate immune defenses of the infected host cell. The remaining 
two proteins are encoded by the M2 gene, and are translated from overlapping reading 
frames on a single M2 mRNA transcript. The M2-1 protein was initially characterized 
as a matrix protein that associated with the viral envelope (Collins and Wertz, 1985), 
but is currently described as an essential transcription factor (Collins et al, 1995; Collins 
et al, 1996), and may also provide a role in virion assembly (Li et al, 2008; Kiss et al, 
2014). The M2-2 protein has been shown to influence the activity of the viral 
polymerase (Table 1.1) (Bermingham and Collins, 1999), and has been shown to be 
dispensible for virus multiplication, although viruses in which the M2-2 reading frame 
is not accessible are growth attenuated.   
 
1.3. Transcription in HRSV 
 Common with all NSNSVs, the gene expression program of HRSV begins with 
the input negative sense RNA genome being copied to produce mRNA transcripts in a 
process known as primary transcription. This activity is mediated by the resident 
polymerase, brought into the infected cell with the input negative sense genome. These 
transcripts are subsequently translated into either structural proteins that are needed for 
subsequent rounds of RNA synthesis and for assembly into viral progeny, or they are 
non-structural proteins that modify the host cell environment facilitating virus 
multiplication. At a later time point, the input genome is replicated to form positive 
sense copies of the input genome, known as anti-genomes, and the events that mediate 
this switch in polymerase activity from a transcriptase to a replicase are not yet 
resolved. The promoters for both these activities are located within the initial 44 
QXFOHRWLGHV RI WKH JHQRPH ¶ HQG EXW WKH VWDUW VLWHV IRU WKHVH GLVWULFW DFWLYLWLHV DUH
different; replication begins at position 1, whereas transcription is initiated alongside 
position 3 (Tremaglio et al, 2013). Subsequently, the transcribing polymerase moves 
along the template LQWKH¶WR¶direction and recognizes and responds to gene start 
and gene end signals that flank each of the HRSV genes. These conserved sequences 
signal the initiation and termination of a single ¶ FDSSHG DQG D ¶ SRO\ $ WDLOHG
mRNA from each of the 10 HRSV genes (Kuo et al, 1996). In contrast, the replicating 
polymerase ignores these gene start and gene end signals, to synthesise a 
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complementary copy of the genome, that is enwrapped in nucleoprotein (N protein) and 
subsequently recruits a polymerase complex to form a helical RNP assembly.  
 Studies using truncated HRSV genomes in which RNP complexes are 
reconstituted in cells by supplying the protein and RNA components in trans have 
shown that replication requires P and L proteins, whereas transcription requires P, L 
and also M2-1 (Yu et al, 1995; Collins et al, 1995; Collins et al, 1996). In the absence 
of M2-1, the abundance of full length transcription products is reduced, suggesting that 
the L protein may be poorly processive, especially during the transcription of long 
genes (Fearns and Collins, 1999). Inclusion of M2-1 in the transcription assay increases 
the abundance of full length transcripts, and taken together, these observations have led 
to the proposal that M2-1 is a processivity factor, allowing the RdRp to reach the end 
of each transcriptional unit (Collins et al, 1995). In addition, the presence of M2-1 in 
reconstitution assays appears to influence the ability of the polymerase to terminate 
transcription at the HRSV conserved gene end signals, leading to increased synthesis 
of multi-cistronic mRNAs spanning two or more transcriptional units (Hardy and 
Wertz, 1998). Whether the polymerase processivity and anti-termination activities of 
M2-1 are related has not been resolved; it is possible that increased polymerase 
processivity is observed when M2-1 prevents the polymerase from terminating at 
sequences resembling gene ends, spuriously located within genes (Sutherland et al, 
2001). 
 More recently, a post-transcriptional role of M2-1 has recently been proposed 
(Rincheval et al, 2017), as well as recent reports that M2-1 is found in association with 
M and RNPs within the virion, thus implicating a structural role of M2-1 in virion 
assembly (Kiss et al, 2014). 
 Attempts to rescue infectious HRSV from cDNAs from which the M2-1 gene 
has been omitted have been unsuccessful (Collins et al, 1995), leading to the proposal 
that M2-1 is essential for virus multiplication, a proposition that is consistent with its 
apparent and critical role in ensuring full length transcription of all 10 HRSV mRNAs. 
However, the possibility that the requirement for M2-1 coding capacity is for one of 
the alternative non-transcription functions cannot be eliminated. Regardless, the 
requirement of M2-1 for the HRSV lifecycle means it represents a promising target for 
the design of antiviral molecules that disrupt one or more of its proposed functions, and 
thus block HRSV multiplication and thus disease.  
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1.4. Macromolecular interactions involved in M2-1 mediated antitermination 
 M2-1 is soluble as a tetramer and directly interacts with RNA and with P in a 
competitive manner (Blondot et al, 2012). It is not clear whether this dual interaction 
with RNA and P is strictly mutually exclusive, or can occur simultaneously on different 
monomers within the tetramer. P is also a tetramer, and residues within its N-terminus 
(residues 1-28) interact with N, supplying RNA-free N monomers to encapsidate the 
newly synthesized replication products in the form of RNPs (Renner et al, 2016). This 
chaperone activity of P maintains N in a soluble form that otherwise has a tendency to 
aggregate as helical assemblies, possibly through interacting with host cell RNAs. The 
C-terminal domain of P, particularly the last 9 residues, interacts with N proteins that 
are components of the viral RNPs, rather than free N monomers (Tran et al, 2007). Just 
N-terminal, proximal to this N-interaction region of P, lies the L-protein interacting site 
(residues 216-239, with crucial hydrophobic residues at 216, 223 and 227) (Sourimant 
et al, 2015). 
 The aforementioned proteins, N, P, L and M2-1 form the minimal requirement 
for the in vitro reconstitution of the HRSV transcription machinery. The variable, 
overlapping and multivalent molecular interactions involved in formation of the 
transcriptase and replicase complexes, as well as the large size, represents a significant 
bottleneck in the in vitro stoichiometric reconstitution and structural analysis of this 
assembly. All of these proteins, partly based on structural and sequence analysis, appear 
to have rigid domains connected by hinges facilitating domain movements (Tanner et 
al, 2014; Tawar et al, 2009; Liang et al, 2015). This can be expected to yield a 
megadalton complex that is inherently flexible thereby resulting in conformational 
heterogeneity in the final assembly, a problem traditionally difficult to address via 
structural biology. Detailed structural understanding of the molecular interactions 
involved in HRSV anti-termination would reveal details of the inter-molecular 
interfaces that could be used for structure-based inhibitor design of antiviral 
therapeutics, in addition to expanding our understanding of the process.  
 Functional and structural homologues of the above-mentioned replicase and 
transcriptase complex associated proteins exist in all other NSNSVs, which also share 
a broadly similar transcriptional programme. However, it is interesting to note that few 
NSNSVs possess a separate protein product that acts as a transcription factor, with only 
the various M2-1 proteins expressed by the pneumoviruses and VP30 expressed by the 
filoviruses, including Ebola virus (EBOV). Like M2-1, VP30 appears to be dispensible 
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for replication but essential for RdRp transcriptional activities, which is dependent on 
VP30 phosphorylation at specific sites (Biedenkopf et al, 2016; Lier et al, 2017). 
Presumably, the many other viruses that do not express such a protein either have 
incorporated protein modules that possess similar functions elsewhere, or utilize a 
transcription mechanism that has no such requirement. In any case, similarities between 
M2-1 and VP30 at both the structural and functional levels mean that the knowledge 
gained from understanding M2-1 structure and function will have important benefits 
for the other viruses within Pneumoviridae and Filoviridae families. 
 
1.5. Crystal structure of HRSV M2-1 protein 
1.5.1. Overexpression and purification of M2-1 for structural studies 
 Full length HRSV (strain A2) M2-1 (194 residues) has a requirement for zinc 
ions during high level expression of folded protein. M2-1 crystallized in two different 
space groups under conditions containing polyethylene glycol and cadmium ions. X-
ray diffraction data was collected and the crystal structure of M2-1 was solved to 2.5 Å 
using the anomalous signal from the cadmium ions and from the bound zinc atoms 
(Tanner et al, 2014). 
 
1.5.2. Molecular architecture of M2-1 
 Monomeric M2-1 consists of three distinct regions linked by unstructured 
flexible sequences (Figure 1.2a). These are the zinc binding domain (ZBD: residues 7-
25), a tetramerization helix (residues 32-49) and the core domain (residues 69-172). 
Connecting the tetramerization helix and the core domain is a flexible linker (residues 
52-67) that is poorly resolved in the crystal structure, and which includes two sites that 
can be phosphorylated (S58 and S61) with important consequences relating to the 
function of M2-1 as a transcription factor. The last 20 residues of the C-terminus are 
not resolved in the electron density as they are unstructured, and many of these residues 
are dispensable, as determined by the rescue of infectious HRSV with these residues 
deleted from the M2-1 ORF. Overall, the molecule has 9 alpha helices and no beta 
strands (Figure 1.2a).  Each monomer of M2-1 interacts with other protomers forming 
a highly stable tetramer. 
 M2-1 tetramerisation is mediated by the oligomerization helix (residues 32-49, 
D1) that buries a series of hydrophobic residues (L36, L43, I46 and M50) on one helix 
 7 
face within a four-helix bundle.  There is also extensive interaction between the ZBD 
of one monomer within the NTD with the core of an adjacent monomer, significantly 
increasing the buried surface area in the tetramer and consequently increasing its 
predicted stability. In the context of the tetramer, the ZBD lies on the N-terminal face 
of the molecule, in close proximity to the RNA binding surface (Figure 1.2b), that also 
includes residues R3 and R4 from the extreme N-terminus of M2-1. 
 The crystal structure of M2-1 provides a framework for the rational analysis of 
residues involved in direct M2-1 interactions with RNA, P and M. In addition, the 
structure will provide a framework on which to explore the mechanisms by which M2-
1 performs its various assigned or proposed functions, as well as understand how these 
multiple functions may be regulated.  
 
1.5.3. RNA binding by M2-1 
 Electrostatic potential calculations on M2-1 revealed that its surface is saturated 
by positively charged residues (Figure 1.3) that form four prominent tracts on the 
tetramer. In order to charaterise potential RNA ligands, and thus provide further 
information regarding the mechanism of M2-1 function, quantitative RNA binding 
studies were performed using fluorescence anisotropy (FA) with different RNA 
sequences. These included polyribonucleotides of A, C, G and U, as well as RNAs 
representing various positive and negative sense HRSV gene-end sequences. These 
sequences were chosen as all functional studies performed to date reveal M2-1 is active 
using mini-genomes in which all HRSV-specific sequences have been eliminated, 
excepting conserved gene start and end sequences. The highest binding affinity of all 
was determined for the polyribonucleotide poly(A) (Kd = 19.1 nM), and comparison of 
the binding specificities of HRSV gene end sequences indicated that positive sense 
sequences exhibited consistently higher affinities than negative sense complements, but 
RNA affinities broadly corresponded with their A content. Variation of up to 5-fold 
were found in M2-1 binding affinity to the different gene-end sequences tested here, 
with SH gene-end binding the tightest (Kd = 46 nM). These data provide evidence that 
the function of M2-LQYROYHVELQGLQJ51$VHTXHQFHVWKDWDUHORFDWHGDWWKH¶HQGRI
HRSV mRNAs, and this location is consistent with its proposed role in influencing the 
process of transcription termination. 
 
1.5.4. Mapping M2-1 residues that interact with RNA. 
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With M2-1:RNA interactions established through FA and identification of high-affinity 
RNA ligands, the contribution of specific M2-1 residues towards RNA binding was 
examined through a variety of M2-1 mutants. These were selected based on the tetramer 
electrostatistics, and the previous NMR based RNA-binding analysis of the M2-1 
globular core (58-177) (Blondot et al, 2012) (Figure 1.4). Multiple residues that lie 
within the core resulted in the reduced RNA binding affinity, including S58D/S61D, 
K92A, K92D, K150A, R151A, R151D, K150A/R151A and K159A. In addition, 
residues R3 and R4 that lie within the N-terminal tip of M2-1 were also found to 
contribute to RNA binding, showing that residues involved in this activity are not 
restricted only to the core, but extended outside. 
 The S58D/S61D double mutant represents a mimic of phosphorylated M2-1, 
and these two serine residues are located above the positively charged surface in the 3D 
structure of M2-1, in a position that is consistent with the observed influence over RNA 
binding. The reduced affinity of this phosphomimetic mutant for RNA suggests that 
M2-1 phosphorylation during the infectious cycle may modulate binding affinity to 
target RNAs, thereby potentially affecting M2-1 function. Comparison between the 
crystal structures of native M2-1 and the phosphomimetic M2-1 mutant S58D/S61D 
suggests that phosphorylation does not cause extensive structural rearrangements 
within the M2-1 tetramer, thus suggesting these functional changes may be due to 
alterations in surface electrostatic potential, and possibly its interaction with an RNA 
binding partner. 
 
1.5.5. Identification of M2-1 residues involved in transcription factor activity  
The aforementioned residues that influence RNA binding were assessed for their 
contribution towards M2-1 antitermination activity using a bicistronic HRSV 
minigenome (Tanner et al, 2014), in which two transcription units were separated by 
functional gene start and gene end sequences, forming a gene junction. This 
minigenome transcription system was set up so that the expression of luciferase from 
the downstream gene was dependent on the presence of M2-1, with the implication 
being that M2-1 was required in order for the polymerase to complete transcription of 
the long upstream gene, and thus gain access to the transcription start site of the 
downstream luciferase gene. Minigenome analysis found that all previously identified 
mutants that exhibited a reduction in RNA binding also showed reduced luciferase 
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expression activity in cellulo, thus suggesting that the RNA-binding activity of M2-1 
was tied to its ability to act as a transcription factor.  
 
1.6 HRSV M2-1 structure: Similarities and differences to other known related 
structures 
 The four-helix bundle formed by the oligomerization helix strongly favors the 
tetrameric organization of M2-1, with the multi-protomer contacts of the ZBD 
increasing oligomer stability. Comparison of the M2-1 X-ray structure with the NMR 
structure of the M2-1 core domain (Blondot et al, 2012) (residues 58-177) reveals a 
similar core fold, suggesting that the core domain can fold independently in the absence 
of all other M2-1 residues, although residues outside the core contribute to RNA 
binding as described above (Blondot et al, 2012). Superposition of the full-length M2-
1 structure and the EBOV VP30 C-terminal domain shows structural similarities, with 
helices 3, 6 and 7 aligning well to each other, while helices 4 and 5 share the same 
orientation (Figure 1.5). This close structural alignment implies strong evolutionary 
ties, and also raises the possibility that these polymerase accessory proteins may act 
through common mechanisms. As described above, the EBOV VP30 is one of only a 
small number of polymerase accessory proteins within the broad group of 
mononegaviruses, and like M2-1 it possess a ZBD and its function is modulated by 
dynamic phosphorylation (Lier et al, 2017). For both M2-1 and VP30, dynamic 
reversible phosphorylation is required for their respective transcription factor 
functionality, with VP30 phospho-ablatant mutants being inactive (Biedenkopf et al, 
2016). 
 The Cys3-His ZBD of M2-1 is noncanonical with no structural homologs found 
by the DALI server (Figure 1.1a), and similarity to the VP30 ZBD is unknown due to 
the current lack of a VP30 ZBD structural model.  Sequence searches suggest that the 
M2-1 ZBD is related to the ZBD of Nup475, which was also shown to bind cadmium 
(Amann et al, 2003). 
 From the crystal structure of M2-1 it is possible to visualize a track that bound 
RNA might take across the surface of each monomer, linking residues that are known 
to influence RNA binding, and also encompassing a contiguous region of positive 
charge. RNA and P have overlapping binding sites on the M2-1 surface and within one 
protomer, thus binding is mutually exclusive. M2-1 binds P in a 1:1 stoichiometry at 
high affinity suggesting that each M2-1 tetramer potentially binds to a P-tetramer. 
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However, the possibility that each monomer within a tetramer might be occupied by 
either RNA or P ligands cannot be ruled out. 
 M2-1 from the closely related human metapneumovirus in the Pneumoviridae 
family shares 38% sequence homology with HRSV M2-1 (Leyrat et al, 2016). HMPV 
M2-1 is also tetrameric with an overall domain organization that is the same as that of 
HRSV M2-1. The final ten residues in the HMPV M2-1 C-terminus were not resolved 
in the structure, suggesting it is disordered, as reported for HRSV M2-1. Interestingly, 
in the crystal structure of HMPV M2-1, one of the monomers has its helical core domain 
flipped out from the rest of the molecule by 60 Å when compared to symmetrically 
arranged protomers in the HRSV M2-1 subunit. This structural plasticity in HMPV M2-
1 was further explored by molecular dynamics simulations and small angle X-ray 
scattering measurements, which were consistent with the possibility that HMPV M2-1 
can adopt both open and closed conformations in solution, with dynamic exchange 
between the two states, with the oligomerization domain as the most rigid part of the 
structure. This flexibility and domain swinging in HMPV M2-1 was postulated to 
increase the surface area of the molecule and allow sampling of a larger volume in 
solution that helps to trap RNA fragments, first proposed through a µfly-casting¶ 
mechanism (Shoemaker et al, 2000). 
 HMPV M2-1 was also crystallized in the presence of adenosine monophosphate 
(AMP) and a five nucleotide long DNA fragment. Although these two molecules are 
non-native binding partners of M2-1, their location on the M2-1 surface corresponded 
to the RNA binding site determined for HRSV M2-1 from NMR and mutagenesis 
studies. A model describing the HPMV M2-1 RNA binding site proposes that the RNA 
may bind along an extended and contiguous tract of positive surface charge, extending 
between the N-terminal and C-terminal faces of each monomer. The length of this 
surface is consistent with binding a oligoribonucleotide of 13 nucleotides in length, 
which coincides with the length of the HRSV gene end consensus sequence. 
 
1.7. A role for M2-1 in virion assembly? 
The RNP within the HRSV virion comprises the minimal essential components 
required for transcription namely RNA, N, P, L and M2-1. This RNP is enclosed within 
the lipid bilayer with a matrix protein (M) in between them, and this assembly appears 
to be mediated by M2-1:M interactions. In a study involving super-resolution 
microscopy of filamentous HRSV particles isolated from infected cells, the M2-1 and 
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M proteins were localized within the enveloped virion with M2-1 being closer to the 
genomic RNA than M (Kiss et al, 2014). Thus, M protein, by simultaneously interacting 
with two chemically different entities (M2-1 and the phospholipid bilayer), appears to 
act as a molecular scaffold.  This overall plan of virion architecture is maintained 
among other members of the Order Mononegavirales, such as those classified in the 
Rhabdoviridae and Filoviridae families, where the corresponding matrix enwraps the 
RNP. However, the resulting RNP and virion morphologies are less consistent; in the 
case of the rhabdoviruses, virions are bullet shaped and the RNP core is found as a 
highly regular and rigid helical assembly, surrounded by a matrix protein sheath. In the 
case of filoviruses (e.g. EBOV) the RNPs are helical, but exhibit a more extended 
morphology that is consistent with the filamentous shape of EBOV virions, which 
suggest RNP flexibility.  
 HRSV M appears able to adopt multiple different oligomeric states in solution, 
although it was crystallized as a monomer (Money et al, 2009). M has N- and C-
terminal domains connected by a 13-residue region, and is globally similar to EBOV 
VP40 in fold, but different in topology. M has a distinct negatively-charged lobe at the 
N-terminus and a positively charged area of 600 Å2 extending from the NTD to CTD.  
The N-terminus of the M protein directly interacts with M2-1, and these two regions 
are proposed to be responsible for simultaneously interacting with M2-1 and the lipid 
bilayer, consistent with its role as a virion scaffold. This arrangement would 
presumably require M2-1 to form a two dimensional layer below M, and also in contact 
with the RNP. From the crystal structure of HRSV M2-1, it is currently unclear how 
the tetramer can arrange into a planar lattice along with M, due to its tendency to 
multimerize as a highly stable tetramer. Whether the alternative conformation of the 
HMPV M2-1 protein could adopt such as layer, with one core domain per tetramer 
being extended, is an interesting possibility. 
 
1.8. Other M2-1 functions. 
Following entry into cells, many NSNSVs are reported to induce the formation of dense 
cytoplasmic structures that contain viral components, and in HRSV infected cells these 
sites are known as Inclusion Bodies (IB) (Norrby et al, 1970). Functionally analogous 
structures have been identified in many other NSNSVs including rhabdoviruses and 
filoviruses (Lahaye et al, 2009; Dolnik et al, 2015; Baskerville et al, 1985) and they are 
often used as histological markers for confirming viral infections. Using a combination 
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of state-of-the-art fluorescence microscopy, super-resolution microscopy and pulse-
chase techniques, HRSV IBs have been shown to represent the sites of active viral RNA 
synthesis (Rinchavel et al, 2017), where both transcription and replication take place. 
Rather than being amorphous aggregates, IBs have a complex organization, and contain 
a spherical sub-structure named as the µInclusion Body Associated Granule¶ (IBAG). 
These are found to be enriched with nascent mRNA and also M2-1, but devoid of other 
proteins of the replication complex (N, P and L).  
 IBAG formation is strictly dependent on viral RNA synthesis and these 
structures are dynamic, undergoing continuous assembly and disassembly cycles, as 
inferred from time-lapse fluorescence studies. The IBAGs were not found to be 
translationally active, suggesting that they may represent a transient compartment 
where newly synthesized viral mRNAs that are associated with M2-1 are stored prior 
to translation in the cytosol.  While the interaction between M2-1 and mRNAs is 
consistent with the previous RNA binding studies described above, that identified 
highest affinities for poly(A) sequences, the established strong association of M2-1 with 
nascent viral RNA in IBAGs may reflects a post-transcriptional function of M2-1 that 
is novel and needs to be explored.  
 
1.9. Conclusions and future outlook 
Solving the X-ray crystal structure of M2-1 represents an important step towards 
understanding the mechanism behind the complex functions of M2-1. However, 
complete clarity of M2-1 functions has yet to be achieved, and M2-1 does not operate 
in isolation from other viral components. Multiple protein-protein and protein-nucleic 
acid interactions execute the anti-termination process, and high resolution structures of 
these other components will greatly aid in revealing the molecular mechanisms behind 
M2-1 activities. Though homology modeling and other theoretical methods can help to 
some extent, accurate understanding requires experimentally determined 3D structures. 
More important than isolated structures are the structures of binary and ternary 
complexes of the HRSV transcriptase and replicase complexes. 
 Structure determination of M2-1 in complex with specific RNA sequences and 
with full-length and/or crucial fragments of P is the next step for structural biologists. 
High-resolution structures that represent snap shots of the anti-termination process 
remain a difficult task, however the recent technical advancement in cryo-electron 
microscopy (cryo-EM) including the development of direct detectors, stable specimen 
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stages, high energy electron guns, phase plates, movie mode imaging and advanced 
image processing strategies, the field of cryo-EM is witnessing a µresolution 
revolution¶. A range of different biological specimens that have otherwise previously 
resisted structure determination like large complexes, membrane proteins, fibrous 
assemblies, low-abundant protein complexes, difficult to crystallize huge assemblies 
like viruses, are now feasible targets for structural studies. Unfortunately, there still 
remains difficulty in structure determination of conformationally flexible, 
heterogeneous protein assemblies of megadalton size. Further insight into the structure 
and function of M2-1 can be obtained through the application of recent advances in 
electron microscopy paired with crystal structures of sub-complexes, in combination of 






Work on HRSV M2-1 in the Barr and Edwards laboratories is supported in part by 
funding from the Medical Research Council (Grant: MR/L007290/1) 
 
References  
1. Amann BT, Worthington MT, Berg JM (2003) A Cys3His zinc-binding domain 
from Nup475/tristetraprolin: a novel fold with a disklike structure. Biochemistry 
42:217-221. 
2 Baskerville SP, Fisher-Hoch GH, Neild, AB, Dowsett (1985) 
 Ultrastructural pathology of experimental Ebola haemorrhagic fever virus 
 infection. J. Pathology 147, pp. 199-209 
3. Bermingham A, Collins PL (1999) The M2-2 protein of human respiratory 
 syncytial virus is a regulatory factor  involved in the balance between RNA 
 replication and transcription. Proc Natl Acad Sci U S A. 1999 Sep
 28;96(20):11259-64. 
4. Biedenkopf N, Schlereth J, Grunweller A et al. (2016) RNA Binding of Ebola Virus 
VP30 Is Essential for Activating Viral Transcription. J Virol 90:7481-7496 
5. Blondot ML, Dubosclard V, Fix J et al. (2012) Structure and functional analysis of 
the RNA- and viral phosphoprotein-binding domain of respiratory syncytial virus 
M2-1 protein. PLoS Pathog 8:e1002734 
6. Bohmwald K, Espinoza JA, Rey-Jurado E et al. (2016) Human Respiratory 
Syncytial Virus: Infection and Pathology. Semin Respir Crit Care Med 37:522-537 
7.  Brady  MT; American Academy of Pediatrics Committee on Infectious 
 Diseases; American Academy of Pediatrics Bronchiolitis Guidelines 
 Committee.  Updated guidance for palivizumab prophylaxis among infants 
 and young children at increased risk of hospitalization for respiratory syncytial 
 virus infection.  Pediatrics. 2014;134(2):415-420. 
8. Collins PL, Hill MG, Camargo E et al. (1995) Production of infectious human 
respiratory syncytial virus from cloned cDNA confirms an essential role for the 
transcription elongation factor from the 5' proximal open reading frame of the M2 
mRNA in gene expression and provides a capability for vaccine development. Proc 
Natl Acad Sci U S A 92:11563-11567 
9. Collins PL, Hill MG, Cristina J, Grosfeld H. (1996) Transcription elongation factor 
of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc 
Natl Acad Sci U S A. 1996 Jan 9;93(1):81-5 
10. Cowton VM, Mcgivern DR, Fearns R (2006) Unravelling the complexities of 
respiratory syncytial virus RNA synthesis. J Gen Virol 87:1805-1821 
11. Dolnik O, Stevermann L, Kolesnikova L et al. (2015) Marburg virus inclusions: A 
virus-induced microcompartment and interface to multivesicular bodies and the late 
endosomal compartment. Eur J Cell Biol 94:323-331 
12. Fearns R. and Collins PL (1999) Role of the M2-1 transcription antitermination 
protein of respiratory syncytial virus in sequential transcription. J Virol. 73:5852±
5864 
13. Hardy RW, Wertz GW (1998) The product of the respiratory syncytial virus M2 
gene ORF1 enhances readthrough of intergenic junctions during viral transcription. 
J Virol 72:520-526 
14. Hu J, Robinson JL (2010) Treatment of respiratory syncytial virus with 
palivizumab: a systematic review. World J Pediatr 6:296-300 
15. Kiss G, Holl JM, Williams GM et al. (2014) Structural analysis of respiratory 
 15 
syncytial virus reveals the position of M2-1 between the matrix protein and the 
ribonucleoprotein complex. J Virol 88:7602-7617 
16. Kuo L, Grosfeld H, Cristina J et al. (1996) Effects of mutations in the gene-start 
and gene-end sequence motifs on transcription of monocistronic and dicistronic 
minigenomes of respiratory syncytial virus. J Virol 70:6892-6901 
17. Lahaye X, Vidy A, Pomier C et al. (2009) Functional characterization of Negri 
bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral 
transcription and replication. J Virol 83:7948-7958 
18. Leyrat C, Renner M, Harlos K et al. (2014) Drastic changes in conformational 
dynamics of the antiterminator M2-1 regulate transcription efficiency in 
Pneumovirinae. Elife 3:e02674 
19. Li D, Jans DA, Bardin PG, Meanger J, Mills J, Ghildyal R. Association of 
respiratory syncytial virus M protein with viral nucleocapsids is mediated by the 
M2-1 protein. J Virol. 2008 Sep;82(17):8863-70. doi: 1128/JVI.00343-08. Epub 
2008 Jun 25. 
20. Liang B, Li Z, Jenni S et al. (2015) Structure of the L Protein of Vesicular Stomatitis 
Virus from Electron Cryomicroscopy. Cell 162:314-327 
21. Lier C, Becker S, Biedenkopf N (2017) Dynamic phosphorylation of Ebola virus 
VP30 in NP-induced inclusion bodies. Virology 512:39-47 
22. Marcelin JR, Wilson JW, Razonable RR et al. (2014) Oral ribavirin therapy for 
respiratory syncytial virus infections in moderately to severely 
immunocompromised patients. Transpl Infect Dis 16:242-250 
23. Money VA, Mcphee HK, Mosely JA et al. (2009) Surface features of a 
Mononegavirales matrix protein indicate sites of membrane interaction. Proc Natl 
Acad Sci U S A 106:4441-4446 
24. Norrby, E., Marusyk, H. & Orvell, C. (1970) Morphogenesis of respiratory 
syncytial virus in a green monkey kidney cell line (Vero). J Virol. 6, 237±242 
25. Palese P, Zheng H, Engelhardt OG et al. (1996) Negative-strand RNA viruses: 
genetic engineering and applications. Proc Natl Acad Sci U S A 93:11354-11358 
26. Renner M, Bertinelli M, Leyrat C et al. (2016) Nucleocapsid assembly in 
pneumoviruses is regulated by conformational switching of the N protein. Elife 
5:e12627 
27. Rincheval V, Lelek M, Gault E et al. (2017) Functional organization of cytoplasmic 
inclusion bodies in cells infected by respiratory syncytial virus. Nat Commun 8:563 
28. Scheltema NM, Gentile A, Lucion F et al. (2017) Global respiratory syncytial virus-
associated mortality in young children (RSV GOLD): a retrospective case series. 
Lancet Glob Health 5:e984-e991 
29. 6KL 7 0F$OOLVWHU '$ 2¶%ULDQ ./ HW DO  *OREDO UHJLRQDO and 
 national disease burden estimates of acute lower respiratory infections due to 
 respiratory syncytial virus in young children in 2015: a systematic review and 
 modelling study. Lancet. 2017 Sep 2;390(10098):946-958. doi: 
 10.1016/S0140-6736(17)30938-8 
30. Shoemaker BA, Portman JJ, Wolynes PG (2000) Speeding molecular recognition 
by using the folding funnel: the fly-casting mechanism. Proc Natl Acad Sci U S A 
97:8868-8873 
31. Sourimant J, Rameix-Welti MA, Gaillard AL et al. (2015) Fine mapping and 
characterization of the L-polymerase-binding domain of the respiratory syncytial 
virus phosphoprotein. J Virol 89:4421-4433. 
32. Sutherland KA, Collins PL, Peeples ME. (2001) Synergistic effects of gene-end 
signal mutations and the M2-1 protein on transcription termination by respiratory 
 16 
syncytial virus. Virology Sep 30;288(2):295-307. 
33. Tanner SJ, Ariza A, Richard CA et al. (2014) Crystal structure of the essential 
transcription antiterminator M2-1 protein of human respiratory syncytial virus and 
implications of its phosphorylation. Proc Natl Acad Sci U S A 111:1580-1585 
34. Tao YJ, Ye Q (2010) RNA virus replication complexes. PLoS Pathog 6:e1000943 
35. Tawar RG, Duquerroy S, Vonrhein C et al. (2009) Crystal structure of a 
nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. 
Science 326:1279-1283 
36. Tran TL, Castagne N, Bhella D et al. (2007) The nine C-terminal amino acids of 
the respiratory syncytial virus protein P are necessary and sufficient for binding to 
ribonucleoprotein complexes in which six ribonucleotides are contacted per N 
protein protomer. J Gen Virol 88:196-206 
37. Tremaglio CZ, Noton SL, Deflube LR et al. (2013) Respiratory syncytial virus 
polymerase can initiate transcription from position 3 of the leader promoter. J Virol 
87:3196-3207 
38. Yu Q, Hardy RW, Wertz GW (1995) Functional cDNA clones of the human 
respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus 
genomic RNA analogs and define minimal trans-acting requirements for RNA 
replication. J Virol 69:2412-2419 
 


































Gene position Protein Function
1. Non-structural protein 
(NS1)
dǇƉĞ/ĂŶĚ////&EĂŶƚĂŐŽŶŝƐƚ ?/&Eɲ ?ɴĂŶƚĂŐŽŶŝƐƚŵĞĚŝĂƚŝŶŐĂŶƚŝǀŝƌĂůƐƚĂƚĞ ?
suppressing maturation of dendritic cells and T-lymphocyte response. Inhibits 
phosphorylation of IFN response element 3 disrupting binding to IFN promoter and 
decreases STAT2 production through degradation.
2. Non-structural protein 
(NS2)
Type I interferon antagonist. Causes degradation of STAT2 and interacts with RIG-I 
to suppress IFN synthesis.
3. Nucleoprotein (N) Sequesters viral RNA forming a nucleocapsid (NC) (protein-RNA complex) which is 
helical. Associates with RNA forming the ribonucleocapsid (RNP) complex
4. Phosphoprotein (P) L-protein cofactor that interacts with the NC to place L onto the RNA. Also interacts 
with M2-1
5. Matrix protein (M) Drive HRSV assembly and budding; vital for virus particle formation, having 
positive and hydrophobic domain important for cytoplasmic membrane binding
6. Short hydrophobic 
protein (SH)
Forms a pentameric ion channel, and is able to inhibit tumour necrosis factor alpha 
 ?dE&ɲ ?ƐŝŐŶĂůŝŶŐ ?ƉĞƌŚĂƉƐŚĞůƉŝŶŐ,Z^sĞǀĂĚĞƚŚĞŝŵŵƵŶĞƐǇƐƚĞŵ
7. Glycoprotein (G) Involved in viral attachment to the host cell
8. Fusion protein (F) Required for fusion of host cell via membranes and promotes syncytia
=9. M2-1 Transcription factor, with other potential roles as discussed in the text
=9. M2-2 Inhibits viral transcription up-regulating RNA therefore mediates the regulatory 
switch from transcription to RNA replication
10. L-protein RNA dependent RNA polymerase (RdRp) transcribing/replicating the viral genome
Table 1.1. List of proteins coded by the HRSV genome and their function
